Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q4DO
|
||||
Former ID |
DIB009396
|
||||
Drug Name |
Dipeptidyl peptidase IV inhibitors
|
||||
Synonyms |
Dipeptidyl peptidase IV inhibitors (type 2 diabetes); Dipeptidyl peptidase IVinhibitors (type 2 diabetes), Bristol-Myers Squibb
|
||||
Indication | Non-insulin dependent diabetes [ICD10:E11.9] | Investigative | [552163] | ||
Company |
Bristol-Myers Squibb Co
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
n12c(nc(c2)C(=O)Nc2n(ncc2)CC)nc(c(c1c1c(cc(cc1)Cl)Cl)CN<br />)C
|
||||
Target and Pathway | |||||
Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [543447] | |
KEGG Pathway | Protein digestion and absorption | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.